Databases in MS research: pitfalls and promises

Abstract

A database is an organized repository of data. Prospective collection of patient information in a database (`databasing') has been attempted by a few consortia of MS investigators over the past 10 years. This approach promises to facilitate epidemiologic research in MS and investigation of the natural history of the disease and how it might be altered by long-term treatments such as interferon beta. Databasing has some advantages over clinical trials in assessing new therapies, primarily because the focus is on long-term effectiveness in an entire population rather than short-term statistical significance in a highly selected population. The limitations of databasing and strategies to overcome these limitations are addressed.

Keywords

multiple sclerosis databases epidemiology natural history prognosis therapy

Get full access to this article

View all access options for this article.

References

Kurtzke JF , Beebe GW , Norman Jr JE. (1979) Epidemiology of multiple sclerosis in U.S. veterans. 1. Race, sex, and geographic distribution . Neurology 29: 1228-1235 .

Kurtzke JF et al. (1973) Studies on the natural history of multiple sclerosis. 7. Correlates of clinical change in an early bout . Acta Neurologica Scandinavica 49: 379-395 .

Kurtzke JF et al. (1977) Studies on the natural history of multiple sclerosis VIII. Early prognostic features of the later course of the illness . J Chronic Dis 30: 819-830 .

McGee M. (1996) Databases for psychiatrists . Harvard Rev Psychiatry 4: 139-145 .

Weinshenker BG , Ebers GC. (1987) The natural history of multiple sclerosis . Can J Neurol Sci 14: 255-261 .

Boiko A. (1997) Guidelines for questionnaires to be used in case-control studies of multiple sclerosis . Neurology (Suppl 2) 49: 575-580 .

Higgins M. (1984) The Framingham Heart Study: Review of epidemiological design and data, limitations and prospects. In: Rao DC ER , Kueler LH , et al. (ed) Genetic Epidemiology of Coronary Heart Disease: Past, Present, and Future. New York: Alan R. Liss, Inc. , 51-64.

Siva A et al. (1993) Trauma and multiple sclerosis: A population-based cohort study from Olmsted County, Minnesota . Neurology 13: 1878-1882 .

Haahr S et al. (1995) Increased risk of multiple sclerosis after late Epstein-Barr virus infection: A historical prospective study . Multiple Sclerosis 1: 73-77 .

10.

Bronnum-Hansen H. (1994) Survival of patients with multiple sclerosis in Denmark: A nationwide, long-term epidemiologic survey . Neurology 44: 1901-1907 .

11.

Pincus T. (1988) Rheumatoid Arthritis: Disappointing long-term outcomes despite successful short-term clinical trials . J Clin Epidemiol (Editorial) 41: 1037-1041 .

12.

Wolfe F , Pincus T. (1995) Data collection in the clinic . Rheumatic Disease Clinics of North America 21: 321-358 .

13.

Pincus T , Stein C. (1995) What is the best source of useful data on the treatment of rheumatoid arthritis: clinical trials, clinical observations, or clinical protocols? (Editorial) Journal of Rheumatology 22: 1611-1617 .

14.

Weinshenker BG et al. (1989) The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability . Brain 112: 133-146 .

15.

Runmarker B , Anderson O. (1993) Prognostic factors in a multiple sclerosis incidence cohort with 25 years of follow-up . Brain 116: 117-134 .

16.

Kantarci O et al. (1998) Survival and predictors of disability in Turkish MS patients . Neurology 51: 765-772 .

17.

Austin HR et al. (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs . New England Journal of Medicine 314: 614-619 .

18.

Gabriel S et al. (1994) Risk of connective-tissue disease and other disorders after breast implantation . New England J Med 330: 1697-1702 .